DOSE MODIFICATION FOR CHINESE PATIENTS ON NIRAPARIB MAINTENANCE TREATMENT FOR PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A POST HOC ANALYSIS

被引：0

作者：

Liu, Z. ^{[1
]}

Wu, X. ^{[2
]}

Zhu, J. ^{[3
]}

Yin, R. ^{[4
,5
]}

Yang, J. ^{[6
]}

Liu, J. ^{[7
]}

Wang, J. ^{[8
]}

Wu, L. ^{[9
]}

Tan, T. ^{[10
]}

Dong, J. ^{[10
]}

机构：

[1] First Hosp Jilin Univ, Dept Oncol, Changchun, Peoples R China

[2] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China

[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Gynecol Oncol, Hangzhou, Peoples R China

[4] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu, Peoples R China

[5] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China

[6] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gynecol Oncol, Beijing, Peoples R China

[7] Sun Yat Sen Univ, Canc Ctr, Dept Gynecol Oncol, Guangzhou, Peoples R China

[8] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Gynecol Oncol, Changsha, Peoples R China

[9] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Gynecol Oncol, Beijing, Peoples R China

[10] Zai Lab Shanghai Co Ltd, RandD Dept, Shanghai, Peoples R China

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷

关键词：

D O I：

10.1136/ijgc-2021-ESGO.333

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：A193 / A194

页数：3

共 50 条

[41] Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
Panici, Pierluigi Benedetti
De Vivo, Antonio
Bellati, Filippo
Manci, Natalina
Perniola, Giorgia
Basile, Stefano
Muzii, Ludovico
Angioli, Roberto
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1136 - 1142
[42] Benefit for female Patients: Bevacizumab in recurrent Platinum-sensitive Ovarian Cancer
Schmalfeldt, Barbara
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (01): : A7 - A8
[43] Evaluation of treatment response to niraparib in patients with platinum-sensitive recurrent ovarian cancer and measurable lesions at baseline: a sub-analysis of the phase III NORA trial
Yin, Rutie
Wu, Xiaohua
Zhu, Jianqing
Yang, Jiaxin
Deng, Ting
Wang, Jing
Wu, Lingying
Liu, Ziling
Gao, Yunong
Wang, Danbo
Lou, Ge
Yang, Hongying
Zhou, Qi
Kong, Beihua
Huang, Yi
Chen, Lipai
Li, Guiling
An, Ruifang
Wang, Ke
Zhang, Yu
Yan, Xiaojian
Lu, Xin
Wang, Li
Tan, Tao
Dong, Juan
GYNECOLOGIC ONCOLOGY, 2021, 162 : S154 - S155
[44] PARP inhibitors as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: Can we afford it?
Smith, H. J.
Haygood, C. L. Walters
Arend, R. C.
Leath, C. A., III
Straughn, J. M., Jr.
GYNECOLOGIC ONCOLOGY, 2015, 137 : 9 - 9
[45] The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer
Gubbi, Ajit
Kendrick, James E.
Finkler, Neil J.
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (10) : 1105 - 1113
[46] Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
Wu, Xiaohua
Zhu, Jianqing
Yin, Rutie
Yang, Jiaxin
Liu, Jihong
Wang, Jing
Wu, Lingying
Liu, Ziling
Gao, Yunong
Wang, Danbo
Lou, Ge
Yang, Hongying
Zhou, Qi
Kong, Beihua
Huang, Yi
Chen, Lipai
Li, Guiling
An, Ruifang
Wang, Ke
Zhang, Yu
Yan, Xiaojian
Lu, Xin
Lu, Weiguo
Hao, Min
Wang, Li
Cui, Heng
Chen, Qionghua
Abulizi, Guzhalinuer
Huang, Xianghua
Tian, Xiaofei
Wen, Hao
Huang, Zhao
Dong, Juan
Zhang, Charlie
Hou, Jianmei
Mirza, Mansoor R.
ECLINICALMEDICINE, 2024, 72
[47] Maintenance therapy utilization in platinum-sensitive recurrent epithelial ovarian cancer: A 'real-world' analysis
Moss, H. A.
Havrilesky, L. J.
Kauff, N. D.
Secord, A. A.
GYNECOLOGIC ONCOLOGY, 2019, 154 : 204 - 204
[48] Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
Takehara, Kazuhiro
Matsumoto, Takashi
Hamanishi, Junzo
Hasegawa, Kosei
Matsuura, Motoki
Miura, Kiyonori
Nagao, Shoji
Nakai, Hidekatsu
Tanaka, Naotake
Tokunaga, Hideki
Ushijima, Kimio
Watari, Hidemichi
Yokoyama, Yoshihito
Kase, Yoichi
Sumino, Shuuji
Suri, Ajit
Itamochi, Hiroaki
Takeshima, Nobuhiro
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02) : 1 - 11
[49] MAINTENANCE OLAPARIB IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A COMPREHENSIVE CANCER CENTRE'S EXPERIENCE
Moreira, I.
Ferreira, M.
Lopes, A. R.
Savva-Bordalo, J.
Abreu, M.
Sousa, S.
Pereira, D.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A241 - A241
[50] NIRAPARIB MAINTENANCE THERAPY IN PATIENTS AGED 75 YEARS AND OLDER WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A SUBGROUP ASSESSMENT OF THE GEICO-88R STUDY
Cueva, Juan
Garcia, Yolanda
Yubero, Alfonso
Gallego, Alejandro
Martinez Bueno, Alejandro
Guerra-Alia, Eva
Quindos, Maria
Sanchez-Lorenzo, Luisa
Barquin, Arantzazu
Fernandez-Perez, Isaura
Martin-Lorente, Cristina
Juarez, Asuncion
Martin-Gomez, Teresa
Salvador, Carmen
Galvez, Fernando
Rubio-Perez, Maria Jesus
Ore Arce, Martin
Cros, Sara
Romeo, Margarita
Gonzalez-Martin, Antonio
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A28 - A28

← 1 2 3 4 5 →